Rapid advances in genomic technologies to screen. diagnose. and treat newborns will significantly increase the number of conditions in newborn screening (NBS). We previously identified four factors that delay and/or complicate NBS expansion: 1) variability in screening panels persists; 2) the short duration of pilots limits information about interventions and health outcomes; 3) recen... https://www.mariameetsanna.com/product-category/haze-styling-powder/